|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.93 CNY | +0.51% |
|
+6.27% | -10.83% |
| Mar. 06 | Maling Aquarius' President Resigns | MT |
| 2023 | Shanghai Kaibao Pharmaceutical CO.,Ltd Announces Executive Changes | CI |
Shanghai Kaibao Pharmaceutical CO.,Ltd reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 540.17 million compared to CNY 538.04 million a year ago. Net income was CNY 82.78 million compared to CNY 81.79 million a year ago.
Basic earnings per share from continuing operations was CNY 0.0791 compared to CNY 0.0782 a year ago. Diluted earnings per share from continuing operations was CNY 0.0791 compared to CNY 0.0782 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -10.83% | 856M | |
| +27.92% | 672B | |
| +27.26% | 570B | |
| -4.59% | 360B | |
| +16.38% | 321B | |
| +9.39% | 300B | |
| +7.42% | 217B | |
| +5.40% | 199B | |
| -8.63% | 204B | |
| -8.58% | 149B |
SHANGHAI KAIBAO PHARMACEUTICAL CO.,LTD 
